Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584428 · ClinicalTrials.gov registry record · NA
High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT00584428 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 61 participants.
The verdict
NCT00584428, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
To evaluate the response rate and the response duration of high dose chemotherapy with autologous bone marrow transplantation as intensification following induction chemotherapy in metastatic breast cancer and to evaluate prospectively the subdivision of patients with metastatic breast cancer according to prognostic groups.
Interventions
- PROCEDURE High-Dose Chemo with Autologous BMT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 1992-06 |
| Est. Completion | 2002-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584428
The ClinicalTrials.gov registry entry for NCT00584428 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High-Dose Chemo with Autologous BMT is the first listed.
NCT00584428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584428 about?
NCT00584428 is a clinical study titled "High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer". To evaluate the response rate and the response duration of high dose chemotherapy with autologous bone marrow transplantation as intensification following induction chemotherapy in metastatic breast cancer and to evaluate prospectively the subdivision of patients with metastatic breast cancer accord...
What is the current status of trial NCT00584428?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 1992-06. Estimated completion is 2002-03.
What interventions are being tested in trial NCT00584428?
The interventions under investigation include: High-Dose Chemo with Autologous BMT (PROCEDURE).
Who is sponsoring clinical trial NCT00584428?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.